Basic Information
NEVODIO TABLET 5MG
TABLET
Regulatory Information
SIN16446P
March 18, 2022
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XC07AB12
Company Information
Active Ingredients
Strength: 5mg
Detailed Information
Contraindications
**Contraindications:** - Hypersensitivity to the active substance or to any of the excipients. - Liver insufficiency or liver function impairment. - Pregnancy and lactation. - Acute heart failure, cardiogenic shock or episodes of heart failure decompensation requiring i.v. inotropic therapy. In addition, as with other beta-blocking agents, nebivolol is contraindicated in: - Sick sinus syndrome, including sinoatrial block. - Second and third degree heart block (without a pacemaker). - History of bronchospasm and bronchial asthma. - Untreated pheochromocytoma. - Metabolic acidosis. - Bradycardia (heart <60 bpm prior to start therapy). - Hypotension (systolic blood pressure <90 mmHg). - Severe peripheral circulatory disturbances.
Indication Information
**Indications:** Hypertension Treatment of essential hypertension. Chronic heart failure (CHF) Treatment of stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients ≥70 years.